The p110δ isoform of PI 3-kinase negatively controls RhoA and PTEN

被引:110
作者
Papakonstanti, Evangelia A.
Ridley, Anne J.
Vanhaesebroeck, Bart
机构
[1] Ludwig Inst Canc Res, London W1W 7BS, England
[2] UCL, Dept Biochem & Mol Biol, London, England
基金
英国生物技术与生命科学研究理事会;
关键词
p110 delta PI 3-kinase; PTEN; RhoA; ROCK; small GTPase;
D O I
10.1038/sj.emboj.7601763
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inactivation of PI 3-kinase (PI3K) signalling is critical for tumour suppression by PTEN. This is thought to be a unidirectional relationship in which PTEN degrades the lipids produced by PI3K, thus controlling cell proliferation, survival and migration. We now show that this relationship is in fact bidirectional, whereby PI3K reciprocally controls PTEN. We report that the p110 delta PI3K negatively regulates PTEN, through a pathway involving inhibition of RhoA. Inactivation of p110 delta in macrophages led to reduced Akt and Rac1 activation, but paradoxically to increased RhoA and PTEN activity. Partial inactivation of p190RhoGAP and a reduced binding of cytoplasmic RhoA to the cyclin-dependent kinase inhibitor p27 both contributed to the increased RhoA-GTP levels upon p110 delta inactivation. Pharmacological inhibition of ROCK, a downstream effector kinase of RhoA, restored all signalling and functional defects of p110d inactivation, including Akt phosphorylation, chemotaxis and proliferation. This work identifies the RhoA/ROCK pathway as a major target of p110 delta-mediated PI3K signalling, and establishes for the first time that PI3K controls itself, via a feedback loop involving PTEN.
引用
收藏
页码:3050 / 3061
页数:12
相关论文
共 58 条
[1]   RhoA inactivation by p190RhoGAP regulates cell spreading and migration by promoting membrane protrusion and polarity [J].
Arthur, WT ;
Burridge, K .
MOLECULAR BIOLOGY OF THE CELL, 2001, 12 (09) :2711-2720
[2]   p27Kip1 modulates cell migration through the regulation of RhoA activation [J].
Besson, A ;
Gurian-West, M ;
Schmidt, A ;
Hall, A ;
Roberts, JM .
GENES & DEVELOPMENT, 2004, 18 (08) :862-876
[3]   Regulation of the cytoskeleton: An oncogenic function for CDK inhibitors? [J].
Besson, A ;
Assoian, RK ;
Roberts, JM .
NATURE REVIEWS CANCER, 2004, 4 (12) :948-955
[4]   Rho and Rac take center stage [J].
Burridge, K ;
Wennerberg, K .
CELL, 2004, 116 (02) :167-179
[5]   The proto-oncogene Fgr regulates cell migration and this requires its plasma membrane localization [J].
Continolo, S ;
Baruzzi, A ;
Majeed, M ;
Caveggion, E ;
Fumagalli, L ;
Lowell, CA ;
Berton, G .
EXPERIMENTAL CELL RESEARCH, 2005, 302 (02) :253-269
[6]   Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis [J].
Cully, M ;
You, H ;
Levine, AJ ;
Mak, TW .
NATURE REVIEWS CANCER, 2006, 6 (03) :184-192
[7]   A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation [J].
Dikic, I ;
Tokiwa, G ;
Lev, S ;
Courtneidge, SA ;
Schlessinger, J .
NATURE, 1996, 383 (6600) :547-550
[8]   P-Rex2, a new guanine-nucleotide exchange factor for Rac [J].
Donald, S ;
Hill, K ;
Lecureuil, C ;
Barnouin, R ;
Krugmann, S ;
Coadwell, WJ ;
Andrews, SR ;
Walker, SA ;
Hawkins, PT ;
Stephens, LR ;
Welch, HCE .
FEBS LETTERS, 2004, 572 (1-3) :172-176
[9]   RAFTK, a novel member of the focal adhesion kinase family, is phosphorylated and associates with signaling molecules upon activation of mature T lymphocytes [J].
Ganju, RK ;
Hatch, WC ;
Avraham, H ;
Ona, MA ;
Druker, B ;
Avraham, S ;
Groopman, JE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (06) :1055-1063
[10]   Regulation of the PTEN phosphatase [J].
Gericke, Arne ;
Munson, Mary ;
Ross, Alonzo H. .
GENE, 2006, 374 :1-9